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Abstract
The leptospiral LigA protein consists of 13 bacterial immunoglobulin-like (Big) domains and is the only purified recombinant
subunit vaccine that has been demonstrated to protect against lethal challenge by a clinical isolate of Leptospira interrogans
in the hamster model of leptospirosis. We determined the minimum number and location of LigA domains required for
immunoprotection. Immunization with domains 11 and 12 was found to be required but insufficient for protection.
Inclusion of a third domain, either 10 or 13, was required for 100% survival after intraperitoneal challenge with Leptospira
interrogans serovar Copenhageni strain Fiocruz L1-130. As in previous studies, survivors had renal colonization; here, we
quantitated the leptospiral burden by qPCR to be 1.2610
3 to 8610
5 copies of leptospiral DNA per microgram of kidney
DNA. Although renal histopathology in survivors revealed tubulointerstitial changes indicating an inflammatory response to
the infection, blood chemistry analysis indicated that renal function was normal. These studies define the Big domains of
LigA that account for its vaccine efficacy and highlight the need for additional strategies to achieve sterilizing immunity to
protect the mammalian host from leptospiral infection and its consequences.
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Introduction
Pathogenic Leptospira species are globally distributed spirochetes
that cause 350,000–500,000 severe human infections annually
with an incidence of .10 cases per 100,000 population in humid,
subtropical regions of the world and a mortality rate of 10%
[1,2,3]. These figures are likely to be underestimates because
leptospirosis is a neglected tropical disease that occurs more
commonly among medically underserved populations [4,5]. The
infection is endemic wherever there is exposure to urine of
reservoir host animals that harbor the organism in their renal
tubules [6]. At least 18 species and more than 200 leptospiral
serovars have been described, many of which were isolated by
cultivation of kidneys from a wide diversity of infested wild and
domestic animals [1,7]. Environmental contamination of water
and soil results in frequent outbreaks of leptospirosis among the
poor in developing countries. Leptospirosis is also emerging
among participants of aquatic sports and adventure tourism [8,9].
In the urban setting, Rattus norvegicus is the most important vector of
human leptospirosis [5]. Serovars of Leptospira interrogans carried by
rats cause life-threatening hepatorenal failure and pulmonary
hemorrhage syndromes in tropical regions, especially where heavy
rainfall occurs in urban areas with poor sanitation and flood
control infrastructure [10]. Commercially available whole-cell
bacterin vaccines for prevention of leptospirosis in animals provide
relatively short-term serovar-specific protection and require
frequent boosters [11]. Although inactivated whole-cell vaccines
have been administered to humans, they are rarely used today
because of their reactogenicity. Thus, there is an urgent need for
development of novel vaccine strategies that provide safe, long-
term, cross-protective immunity.
Recombinant surface-exposed outer membrane proteins (OMPs)
are attractive subunit vaccine candidates because in contrast to the
lipopolysacchride, leptospiral OMPs are relatively well conserved
and those that are surface-exposed represent potential targets for
immune-mediated defense mechanisms. We have developed a suite
of complementary approaches for determining which leptospiral
OMPs are surface-exposed, including surface immunofluorescence,
surface biotinylation, surface proteolysis, surface immunoprecipita-
tion, and surface ELISA [12,13,14,15]. Using these approaches, a
number of transmembrane OMPs and surface lipoproteins have
been identified [16,17]. Despite the rapid increase in knowledge
about leptospiral OMPs, progress in understanding their vaccine
potential has been slow. Although LipL32 is the most abundant
pathogenic leptospiral OMP [18], purified, recombinant LipL32 has
no detectable vaccine efficacy [19]. Nevertheless, hamsters immu-
nizedwithrecombinantbacillusCalmette-GuerinexpressingLipL32
were partially protected from lethal challenge [20] and there is
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DNA-based vectors [21,22]. Synergistic immunoprotection has been
observed using a combination of leptospiral OMPs, OmpL1 and
lipidated LipL41, expressed as membrane proteins in E. coli [23].
Leptospiral immunoglobulin-like (Lig) proteins are of great
interest as mediators of leptospiral pathogenetic mechanisms, as
serodiagnostic antigens, and as effective recombinant vaccinogens
[24,25,26,27,28]. At least two of the three members of the Lig
protein family are outer membrane lipoproteins containing a
tandem series of bacterial immunoglobulin-like (Big) domains [29].
Lig protein expression is associated with virulence and is strongly
and rapidly induced by increasing the osmolarity of the culture
medium to physiologic levels found in the mammalian host,
suggesting that they may be involved in the initial stages of host
tissue colonization [30,31]. LigA consists of 13 Big domains, the
first six of which are nearly identical in sequence to those in LigB,
while the last seven are unique to LigA [32] and mediate inter-
actions with host extracellular matrix proteins and fibrinogen
[24,33]. One study has found that the region shared by LigA and
LigB was not immunoprotective [27], while another study
reported that this region conferred some immunoprotective
activity [34]. In contrast, several groups have reported that
immunization with the LigA-unique region induced protection
from lethal infection either in a mouse model [28] or in the
hamster model [27,35] of leptospirosis. Although hamsters
surviving leptospiral challenge were found to have sublethal
kidney infection, both the extent of infection and its effects on the
kidney, the key target organ in leptospirosis, were not well
understood. In this study, we determined which LigA domains are
most strongly associated with immunoprotection and the effect of
LigA immunization on the burden of infection and the
histopathology in the kidney. Our results show that protection
from lethal infection required immunization with domains 11 and
12 along with a third domain, either 10 or 13.
Materials and Methods
Leptospiral strain and cultivation
L. interrogans serovar Copenhageni strain Fiocruz L1-130 was
maintained in Ellinghausen-McCullough-Johnson-Harris (EMJH)
medium [36] supplemented with 1% rabbit serum (Rockland
Immunochemicals, Gilbertsville, PA) and 100 mg/ml 5-fluoroura-
cil at 30uC in a shaker incubator. Organisms were passaged no
more than five times prior to hamster challenge. Hamster tissues
were cultured in semi-solid EMJH or semi-solid Probumin
Vaccine Grade Solution (Millipore, Billirica, MA) containing
0.2% Bacto agar (BD, Franklin Lakes, NJ) and 100 mg/ml 5-
fluorouracil in a stationary incubator at 30uC and were examined
for leptospiral growth for up to two months.
Preparation of recombinant proteins
PCR primers were designed to amplify gene fragments en-
coding various immunoglobulin-like domains from ligA of L.
interrogans serovar Copenhageni strain Fiocruz L1-130 (Table 1).
DNA amplicons, which included Nde I and Xho I restriction
endonuclease sites, were ligated into pET-20b(+) (Novagen), pro-
viding a carboxy-terminal His6 tag, and used to transform
Escherichia coli BLR(DE3)pLysS (Novagen). Protein expression
was induced with isopropyl-b-D-thiogalactopyranoside at 30uC
and soluble proteins were released with BugBuster (Novagen) and
purified with nickel-affinity chromatography as previously de-
scribed [25]. All proteins were stored at 4uC after dialysis in PBS.
Hamster immunization
Groups of four female Syrian hamsters, 5 to 6 weeks of age
(Harlan Bioscience, Indianapolis, IN), were immunized subcuta-
neously with 100 mg of recombinant protein, PBS, or 1610
8 heat-
killed (56uC for 1 h) leptospires (HKL) in a total volume of 0.5 mL
on days 0, 14 and 28 with Freu ¨nd’s adjuvant (complete adjuvant
for the first immunization, incomplete adjuvant for subsequent
immunizations). Blood samples were obtained two days before the
first immunization and 10 to 12 days after each immunization via
the retro-orbital route. All animal procedures were approved by
the Veterans Affairs Greater Los Angeles Healthcare System
Institutional Animal Care and Use Committee and adhere to the
United States Health Research Extension Act of 1985 (Public Law
99–158, November 20, 1985, ‘‘Animals in Research’’), the National
Institutes of Health’s Plan for Use of Animals in Research (Public Law
103–43, June 10, 1993), U.S. Government Principles for the
Utilization and Care of Veterbrate Animals Used in Testing,
Research, and Training, Public Health Service Policy on Humane
Care and Use of Laboratory Animals, the United States Depart-
ment of Agriculture’s Animal Welfare Act & Regulations, and
Veterans Health Administration Handbook 1200.7.
ELISA. Ninety-six-well ELISA microtiter plates (Immulon
4HBX,Thermo Fisher, Waltham, MA) were coated either with
100 mLo f1 0mg/mL of recombinant LigA protein or 1610
9 heat-
inactivated leptospires/mL diluted in PBS, pH7.2 (Invitrogen,
Carlsbad, CA), by overnight incubation at 4uC. The plates were
allowed to warm to room temperature (RT), washed once with
200 mL of PBS, and blocked with Protein-Free Blocking Buffer
(PFBB, Thermo Fisher, Rockford, IL) for 1 to 2 h at RT. Wells
were washed with PBS, sera diluted with PFBB were added in a
volume of 100 mL, and plates were incubated for 1 h at 37uC.
Non-binding antibodies were removed with three PBS washes, and
Horseradish peroxidase (HRP)-conjugated anti-Syrian hamster
immunoglobulin secondary antibody (Jackson ImmunoResearch,
West Grove, PA) 1:5000 was incubated for 30 min at RT.
Following three washes with PBS, 100 mL of 1-Step Turbo TMB
HRP substrate (Thermo Fisher) was added and incubated for 30
min at RT with shaking. The reaction was stopped by the addition
of 50 mLo f2MH 2SO4, and plates were immediately read in a
Bio-Rad 550 Microplate Reader at 450 nm. End-point titers were
defined as the highest titer that yielded a reading two standard
Author Summary
Leptospirosis is the most widespread bacterial infection
transmitted to humans from host animals that harbor the
bacteria in their kidneys. Human infections caused by the
bacterium, Leptospira interrogans, frequently result in a life-
threatening illness characterized by jaundice and kidney
failure. Vaccines are urgently needed to prevent leptospi-
rosis in populations at risk. The leptospiral protein, LigA, is
a promising vaccine candidate because it is the first
purified protein to be shown to protect animals from fatal
leptospirosis. The goal of this study was to determine
which of LigA’s 13 domains are required for the protective
effect. Immunization with domains 11 and 12 was found to
be required, but was insufficient, for protection. A third
domain, either 10 or 13, was required for 100% survival. As
in previous studies, residual bacteria were cultured from
the kidneys of survivors. However, in contrast to previous
studies, we determined the amount of bacterial DNA in the
kidneys as a measure of vaccine efficacy. We also
examined the kidneys microscopically for signs of damage
and measured blood chemistries to assess kidney function.
These are important steps towards developing vaccines
that provide protection from kidney damage and infection.
Immunoprotective Three-Domain Region of LigA
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hamsters. Geometric mean end-point titers were calculated as
previously described [37].
Challenge and sample collection
Fourteen days after the third immunization (day 42), hamsters
were challenged intraperitoneally with 1610
3 L. interrogans serovar
Copenhageni strain Fiocruz L1-130 in 0.5 mL of EMJH. The
animals were weighed daily and observed for end-point criteria,
including loss of appetite, gait or breathing difficulty, prostration,
ruffled fur, or weight loss of $10% of the animal’s maximum
weight. Animals that reached end-point criteria were euthanized
with isoflurane and tissue samples were collected in formalin for
histopathology or incubated overnight at 4uC in RNAlater
(Ambion, Austin, TX) and stored at 280uC. Processing tissues
for histopathology involved formalin fixation, paraffin embedding,
sectioning, and periodic acid Schiff (PAS) staining in a Dako
automated slide processor. Blinded scoring of kidney sections used
a scale of 0 to 5 for the extent of histopathology, ranging from
normal to severe renal tubular damage, based on the degree of
hyaline cast deposition, interstitial inflammation, mitosis, Bow-
man’s space dilation, tubular atrophy and associated capsular
depression. Blood was collected for serology and chemistry analysis
(Antech Diagnostics, Irvine, CA). 100 mL of blood or pulverized
kidney or liver were inoculated into semi-solid medium at dilutions
of 1:100 and 1:10,000 and incubated at 30uC.
Microscopic agglutination test (MAT)
Sera collected at euthanasia were examined at a 1:50 dilution by
MAT as previously described [38] with live L. interrogans serovar
Copenhageni strain Fiocruz L1-130. Briefly, heat-inactivated serum,
diluted in physiologically buffered water, pH7.6, was incubated
overnight at 4uCw i t h2t o4 610
8 leptospires/mL and examined
under dark-field microscopy for .50% reduction in the number of free
leptospires when compared with serum from uninfected animals.
Quantitative PCR (qPCR)
Kidneys were stored in RNAlater and DNA was extracted with
DNeasy Blood and Tissue kit according to the manufacturer
instructions (Qiagen, Valencia, CA) with modifications. 15 to
25 mg of kidney were immersed in 360 mL of ATL buffer and the
tissue was homogenized in a 24-Fast Prep tissue homogenizer (MP
Biomedicals, Solon, OH) using lysing matrix A with a setting of
6 m/s for 40s. 40 mL of proteinase K at a concentration of 15 mg/
mL of protein were added and the samples were incubated for 3 h
at 37uC. Two volumes of AL buffer-ethanol (1:1) were added and
the mixture was applied to a spin column, on which the bound
DNA was washed with washing solutions 1 and 2 and eluted with
200 mL of AE buffer-water (1:4). The purified DNA was stored at
280uC until use.
The extracted DNA was used in a qPCR using the Bio-Rad iQ5
Real-time System (Bio-Rad, Hercules, CA). 100 ng of total DNA
was combined with 1 mM of each primer and 12.5 mL iQ SYBR
Green Supermix (Bio-Rad) and brought to a final volume of 25 mL
with nuclease-free water (Ambion). 4 samples were run per group
and each sample was run in duplicate. qPCR primer pairs were
LipL32-f, 5-CGCGTTACCAGGGCTGCCTT-39, and LipL32-r,
59-CGCTTGTGGTGCTTTCGGTG-39, and hamster GAPDH-
f, 59-CTGGTTACCAGGGCTGCCTT-39, and GAPDH-r, 59-
CCGTTCTCAGCCTTGACTGTGC-39, resulting in amplicons
of 152 bp and 146 bp, respectively. The PCR protocol consisted
of an initial incubation step at 95uC for 12.5 min followed by 40
cycles of amplification (95uC for 15 s, 57uC for 30 s and 72uC for
30 s). The level of the lipL32 gene of L. interrogans was normalized
to that of hamster gapdh, using Bio-Rad iQ5 software and
Microsoft Excel. Standard curves were generated for each gene
ranging from 10 to 1.6610
6 copies of Leptospira (20-fold dilutions)
and 0.02 to 200 ng (10-fold dilutions) of hamster DNA.
Statistics
Survival differences between groups were analyzed by Fisher’s
Exact Test using GraphPad InStat version 3.10 (GraphPad
Software Inc., La Jolla, CA). One-way analysis of variance
(ANOVA) was used to test for differences between multiple ($3)
groups using a P value,0.05. For ordinal data, such as the
histopathology scores, the Kruskal-Wallis one-way ANOVA with
Dunn’s post-test was included. The unpaired, two-tailed Student’s
Table 1. Recombinant LigA proteins.
Protein
a Amino acidcoordinates
b MW (Da) Primers
c
LigA79-13 L631-P1224 63,422 f-AACATATCTCATATGCTTACCGTTTCCAACACAAACGCCAA
r-TTCCTCGAGTGGCTCCGTTTTAATAGAGGCTAAT
LigA79-11 L631-A1033 42,991 f-AACATATCTCATATGCTTACCGTTTCCAACACAAACGCCAA
r-GACGTCCTCGAGAGCAGAAGTGACATACAAGGTAGTAGA
LigA79-9 L631-A851 24,034 f-AACATATCTCATATGCTTACCGTTTCCAACACAAACGCCAA
r-AGTCTCGAGCGCTGCGGTAACGGATAATTTGGA
LigA10-13 E852-P1224 40,602 f-ACGCTTACGCATATGGAACTTACTGAGATTGTGCTAAATCC
r-TTCCTCGAGTGGCTCCGTTTTAATAGAGGCTAAT
LigA10-12 E852-E1124 30,085 f-ACGCTTACGCATATGGAACTTACTGAGATTGTGCTAAATCC
r-GCGTAGCTCGAGCTCGTCATTGACGAATATCCA
LigA11-13 R943-P1224 31,233 f-CATCAATGACATATGAGAATAGCTTCAATCGAAGTAACACC
r-TTCCTCGAGTGGCTCCGTTTTAATAGAGGCTAAT
LigA11-12 R943-E1124 20,716 f-CATCAATGACATATGAGAATAGCTTCAATCGAAGTAACACC
r-GCGTAGCTCGAGCTCGTCATTGACGAATATCCA
LigA12-13 V1034-P1224 21,645 f-ATACAGTCTCATATGGTCCTTATTGACATAGAAGTCAAGCC
r-TTCCTCGAGTGGCTCCGTTTTAATAGAGGCTAAT
aLigA protein designations list the first and last domains included in the construct; 79 indicates a half domain.
bCoordinates refer to the first and last amino acids in the LigA protein of L. interrogans serovar Copenhageni strain Fiocruz L1-130.
cForward (f) and reverse (r) primer sequences, including an Nde Io rXho I site, respectively, are listed in the 59 to 39 direction.
doi:10.1371/journal.pntd.0001422.t001
Immunoprotective Three-Domain Region of LigA
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between two groups using a P value,0.05.
Results
Recombinant LigA proteins and hamster response to
immunization
Eight clones were designed to express recombinant proteins
corresponding to various LigA domains from the second half of
domain 7 to domain 13 (Table 1) of L. interrogans serovar
Copenhageni. All proteins were expressed and purified as soluble
proteins and found to be stable at 4uC after dialysis in sterile PBS.
These proteins were employed as hamster immunogens in two
independent experiments (#1 and #2) and as antigens in an
indirect ELISA to measure the corresponding antibody response.
As shown in Figure 1, hamsters had higher antibody titers after the
third immunization than after one or two immunizations (one-way
ANOVA with test for linear trend, P,0.05), except in the HKL
(experiment #2) and LigA79-11 groups. There was no correlation
between the antibody titer and the number of domains in the LigA
protein (Pearson correlation coefficient 0.29, P.0.05).
Immunoprotective LigA domains
Hamsters were challenged with virulent L. interrogans via the
intraperitoneal route and observed daily, with a 10% decrease in
body weight included as an end-point criterion. Body weight was
found to be a useful measure of the response of animals to
challenge; a decrease in body weight was the earliest observable
sign of clinical leptospirosis. In contrast to animals that were
immunized with LigA79-13 and exhibited 100% challenge survival
(Figure 2A, Table 2), non-surviving animals that were sham-
immunized with PBS began to lose weight on day 8 after the
challenge and reached -10% of peak weight within 48 h
(Figure 2B).
Immunization with different recombinant LigA protein con-
structs (Table 1) resulted in dramatically different challenge
outcomes (Table 2 and Figure 3). In both experiments, there
was 100% survival in hamsters immunized with either the LigA79-
13 or LigA10–13 proteins. In experiment #1, immunization with
either the LigA79-11 protein or the LigA12-13 protein resulted
in,50% survival. This result indicated that no single LigA domain
was sufficient to afford 100% immunoprotection. For this reason,
a second experiment was performed to identify the LigA domain(s)
and the minimum number of domains required to protect
hamsters from lethal challenge. Interestingly, both the LigA10-
12 and the LigA11-13 proteins were both effective immunogens,
while the LigA11-12 protein consisting of their shared domains
afforded only 25% survival. Taken as a whole, these data indicate
that LigA domains 11 and 12 are required but not sufficient to
induce 100% survival. A recombinant LigA protein construct
consisting of at least three specific Big domains is needed to induce
a maximally protective immune response. The protective effect
was not merely a reflection of antibody titer; as there was no
correlation between survival and geometric mean end-point titer
(Figure 1, one-way ANOVA, P . 0.05).
Effect of LigA immunization on organ colonization
As previously reported [27], immunization with LigA proteins
provided non-sterilizing immunity, as organisms were isolated
from the kidneys of animals surviving challenge. Cultures of
kidney tissue from all hamsters surviving to 28 days were positive
(Table 2). In contrast, only 3 and 10 of 56 animals had positive
liver and blood cultures, respectively (data not shown). One non-
surviving animal immunized with LigA11-12 had a positive blood
Figure 1. Antibody response in hamsters immunized with recombinant LigA proteins or heat-killed leptospires (HKL). Total hamster
immunoglobulin responses to immunogens were measured by ELISA. Geometric mean end-point titers and standard deviations (n=4) are shown
after the first (gray), second (blue), and third (black) immunizations. In all cases, pre-immune sera were negative. Recombinant LigA proteins are
represented by their domain numbers. Asterisks indicate proteins that provided 100% protection against lethal challenge.
doi:10.1371/journal.pntd.0001422.g001
Immunoprotective Three-Domain Region of LigA
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kidney infection was reflected in lower weight gain of hamsters
after challenge (Figure 4). Among the surviving hamsters, those
immunized with LigA10-13 had a non-statistical trend of gaining
less weight after challenge than those immunized with LigA79-13
or heat-killed leptospires. Infection resulted in the formation of
agglutinating antibodies; the MAT was positive in nearly all LigA-
immunized animals surviving for 28 days (Table 2). The only
exceptions were one animal from the HKL control group and two
from the LigA12-13 group that met end-point criteria early, the
latter presumably because these animals had insufficient time to
develop agglutinating antibodies.
To more accurately assess the leptospiral burden, DNA from
kidneys was analyzed by qPCR. As shown in Table 2 and Figure 5,
groups immunized with LigA fragments had a mean of 1.2610
3 to
8610
5 copies of leptospiral DNA per microgram of kidney DNA.
As expected, kidneys from animals immunized with heat-killed
leptospires had a lower leptospiral burden than groups immunized
with LigA proteins such as LigA10-12, LigA11-13, LigA10-13
(experiment #1) and LigA79-13 (experiment #1) (non-parametric
ANOVA, Dunns post-test, P,0.05). Leptospiral burden appeared
to have a significant effect on animal health as reflected in the
weight of surviving hamsters; there was an inverse correlation
(Pearson correlation coefficient -0.51, P,0.05) in experiment #2
between the percent weight gain during the last week of the
experiment and the copies of leptospiral DNA per mg of kidney
tissue DNA. However, there were no significant differences in the
leptospiral burden among groups with 100% survival immunized
with different LigA proteins (Non-parametric ANOVA, P.0.05).
Figure 2. Hamster weight as an end-point for leptospiral
infection. Animals were weighed at the time of challenge and daily
thereafter for 28 days. Data are shown for experiment #2. A. Animals
immunized with recombinant LigA79-13 progressively gained weight
(lines represent individual animals). B. Control animals sham-immu-
nized with phosphate-buffered saline (PBS) had stable or increasing
weights until day 8 or 9 after challenge, after which they lost weight
and met the end-point criterion of a 10% weight decrease (lines
represent individual animals).
doi:10.1371/journal.pntd.0001422.g002
Table 2. Summary of immunoprotection outcomes
a.
Immunogen
(LigA Domains)
Survival
b
(%)
MAT
(Positives/Total)
Culture
c
(Positives/Total)
Histology
c
(Mean Score)
qPCR
c,d
(Log10)
Experiment 1
79-13 100 3/3 4/4 ND 5.7962.0
79-9 0* 1/3 4/4 ND 3.9260.3
79-11 50 2/4 2/4 ND 3.10**60.8
10-13 100 4/4 4/4 ND 5.9260.8
12-13 50 0/4 4/4 ND 5.5361.3
HKL 100 3/3 0/4 ND 2.48**60.6
PBS 0* 0/1 4/4 ND 4.6661.0
Experiment 2
79-13 100 4/4 4/4 1.0 4.1360.2
10-13 100 4/4 4/4 2.5 4.9061.0
10-12 100 4/4 4/4 3.3** 4.8160.4
11-13 100 4/4 4/4 1.75 5.6161.2
11-12 25 4/4 1/4 3.3** 4.2960.8
HKL 100 3/4 0/4 1.25 2.39**60.2
PBS 0* 3/3 2/4 ND 2.72**6 0.2
aAbbreviations: HKL = heat-killed leptospires, PBS = phosphate-buffered saline, ND = not done.
bFour animals per group. *Statistically different from the LigA79-13 group (Fisher’s exact test, P,0.05).
cData refer to kidney analysis. Means are shown for Histology and qPCR (n=4).
**Statistically different from the LigA79-13 group (ANOVA, Dunn post-test, P,0.05).
dExpressed as copies per microgram of tissue DNA.
doi:10.1371/journal.pntd.0001422.t002
Immunoprotective Three-Domain Region of LigA
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Hemorrhagic areas were frequently noted on gross examination
of the kidney and lungs of animals that did not survive challenge.
Organs of survivors were usually normal in appearance but the
kidneys occasionally appeared shrunken, pale, or had surface
depressions indicating underlying infarction. Histopathological
changes in the kidneys were largely limited to tubulointerstitial
damage. Glomeruli were uniformly unaffected, except for one case
of hyaline deposition seen in an HKL-immunized hamster.
Although Bowman’s space was dilated in some cases, the cells of
the glomerulus were unaffected. Tubulointerstitial changes
included renal tubular damage, encompassing changes of thinning
of renal tubular epithelial cells (compare Figures 6A and 6B),
increasing hyaline cast deposition, mitosis, tubular atrophy
(Figure 6C), interstitial inflammation (Figure 6D), and associated
capsular retraction (Figure 6E). Renal tubular obstruction was the
most likely cause of hyaline cast deposition of the material staining
intensely with PAS (Figure 6F). Other changes due to tubular
obstruction were dilated Bowman’s space with or without hyaline
casts. Mitoses were seen in only 2 cases, which further supported
tubular injury because the rate of tubular cell turnover is normally
close to zero. As shown in Table 2, scores based on the extent of
renal tubular damage were higher in groups immunized with the
LigA10-12 and LigA11-12 proteins, suggesting that immunization
with these constructs was associated with relatively more
histopathology than other LigA constructs. Groups immunized
with HKL and the LigA79-13 protein had lower renal histopa-
thology scores (Table 2) and there was an inverse correlation
between renal histopathology score and weight gain (Pearson
correlation coefficient -0.75, P,0.01). There was also an inverse
correlation between renal histopathology score and leptospiral
burden (Pearson correlation coefficient 20.84, P,0.01) for
animals with.1.5610
4 copies of leptospiral DNA/mg of tissue
Figure 3. Mapping of the immunoprotective segment of LigA. Recombinant LigA proteins were tested for protective efficacy. The number of
animals surviving (survivors/total) and days to endpoint after challenge are shown. Surviving animals were observed for up to 28 days. Ig-like
domains of fully protective proteins are represented by dark symbols with green numbers while Ig-like domains of partially protective and non-
protective proteins are represented by white symbols with red numbers.
doi:10.1371/journal.pntd.0001422.g003
Figure 4. Percentage weight gain in hamsters immunized with
protective immunogens. Mean and standard deviation (n=4) of
percent weight gain from challenge to 28 days in groups that had 100%
survival, including hamsters immunized with recombinant LigA proteins
(represented by their domain numbers), heat-killed leptospires (HKL)
and a non-immunized and unchallenged control (CTRL) group.
doi:10.1371/journal.pntd.0001422.g004
Immunoprotective Three-Domain Region of LigA
www.plosntds.org 6 December 2011 | Volume 5 | Issue 12 | e1422Figure 5. Leptospiral burden in kidney tissue. Kidney tissue was subjected to DNA extraction and real-time PCR to measure the leptospiral
burden per microgram of tissue DNA. Means are depicted as bold horizontal bars along with standard deviations. Animals that survived to 28 days
(blue diamonds) had higher leptospiral burdens than those that met end-point criterion early (red circles). Of the groups with 100% survival to 28
days, animals immunized with heat-killed leptospires (HKL) had lower bacterial burdens than those immunized with LigA fragments. LigA-immunized
groups that survived up to 28 days were used for statistical comparisons (one-way ANOVA, P,0.05).
doi:10.1371/journal.pntd.0001422.g005
Figure 6. Renal histopathology showing tubulointerstitial changes. Representative PAS-stained kidney sections obtained from hamsters 28
days after leptospiral challenge showing, A. Normal tubular epithelium (40x); B. Moderate tubular damage (40x); C. Severe tubular atrophy (40x); D.
Interstitial inflammation (arrow, 40x); E. Tubular scarring with depressed renal capsule (arrow, 4x); and F. Tubular deposition of intensely PAS-positive
material consistent with Tamm-Horsfall glycoprotein (arrowheads, 40x).
doi:10.1371/journal.pntd.0001422.g006
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by interstitial nephritis) may be partially effective at clearing
residual infection.
Serum chemistries were measured to evaluate liver and kidney
function of the hamsters (Table 3). Alanine aminotransferase and
alkaline phosphatase levels were moderately elevated in all groups,
consistent with hepatitis and cholestasis, respectively. However,
bilirubin levels were universally normal, indicating that hepatic
cholestasis had not progressed to biliary obstruction. Blood urea
nitrogen (BUN) levels were increased in all groups and extremely
elevated in the PBS control, while creatinine was low in all groups
and elevated in the PBS control group (one-way ANOVA with
Dunn’s post test, P,0.05), indicating that renal dysfunction and/
or dehydration contributed to mortality in these animals. In
contrast, serum creatinine and BUN levels were universally
normal in survivors, indicating that the renal tubular damage
observed by histopathology had not progressed to frank kidney
failure.
Discussion
In this study, we identified the LigA domains involved in
protecting hamsters from lethal leptospiral infection. Intraperito-
neal inoculation was performed with 1000 L. interrogans serovar
Copenhageni strain Fiocruz L1-130, resulting in a lethal infection
in all control animals (Table 2, Figure 3). This is the same
challenge dose used in a previously successful LigA protection
study and is estimated to be ,20-fold over the LD50 for this strain
[27]. We found that a LigA protein construct consisting of at least
three Big domains is required for immunoprotection and that the
11
th and 12
th specific Big domains must be included in this
construct. Given that the average pairwise sequence identity
among LigA Big domains is only 37% [32], the domains identified
here are likely to be antigenically unique and contain unique
immunoprotective epitopes. Compared to maximally protective
proteins, less protective LigA proteins elicited similar antibody
titers in hamsters (Figure 1), suggesting that protection was not
solely due to the antigenicity of the respective LigA vaccine. The
mechanism of LigA mediated immunoprotection has not been
elucidated, but may involve the disruption of a key function of
LigA in leptospiral pathogenesis and/or the enhancement of host
defense mechanisms. One key function of LigA is to mediate
binding of Leptospira to host molecules such as fibronectin and
fibrinogen [24]. Fibronectin- and fibrinogen-binding activity is
found within domains 7 through 13 of LigA, with the carboxy-
proximal domains 10 to 13 being required for fibronectin binding
(unpublished study, H. A. Choy). Finer mapping of the LigA
binding activities may give clues as to the possible immunopro-
tective mechanism.
As noted previously, LigA immunization converts an otherwise
lethal infection into a sublethal kidney infection [27]. The burden
of infection and its effects on vaccinated hamsters, qPCR and a
histopathology scoring system were included as quantitative
outcome measures. To our knowledge, this is the first vaccine
study to use qPCR to quantitate leptospiral burden in animals
after challenge. The application of qPCR to leptospiral vaccine
studies allows for the accurate determination of the leptospiral
burden, especially in the kidney, where colonization can lead to
kidney damage and/or urinary shedding of the pathogen. We
found that the heat-killed leptospires may not confer sterilizing
immunity. Although the kidneys from the immunized animals
were culture negative, leptospiral DNA was detected by qPCR.
Reverse transcription-qPCR studies are needed to determine
whether the low levels of DNA in these kidneys represent viable
spirochetes or are remnants of leptospires killed by the host
immune system. Comparison of quantitation results among
surviving hamsters shows that immunization with as few as three
LigA domains did not result in significantly higher levels of renal
colonization than immunization with longer constructs such as the
seven-domain LigA79-13 protein (Figure 5). However, immuniza-
tion with LigA10-12 did lead to greater histopathology, indicating
different protective effects of the LigA10-12 and LigA11-13
constructs (Table 2).
Histopathology analysis of kidney sections was performed using
PAS staining, which is useful for evaluating many different types of
nephropathology, including the severity of tubulointerstitial
damage in our study. PAS staining facilitated identification of
proximal tubules by their carbohydrate-containing brush border,
evaluation of tubular basement membrane changes, as well as
tubular atrophy (Figures 6A, B, and C). A striking finding of our
study was the identification of intensely staining protein casts in the
tubules of 32% of animals, both in solid and ‘‘bubbly’’ deposition
Table 3. Chemistry results
a.
Group
(LigA Protein)
BUN
b
(mg/dL)
AlkPhos
b
(IU/L)
Calcium
(mg/dL)
Creatinine
(mg/dL)
Phos
b
(mg/dL)
SGPT
b
(IU/L)
Total bilirubin
(mg/dL)
Total protein
(g/dL)
79-13 2162 12768*1 3 60.7 0.360.1 7.660.5 64611 0.160 6.660.4
10-13 25657 8 614 12.862.2 0.2606 . 8 61.5 57626 0.160 5.661
10-12 26667 2 64 11.661.8 0.2606 . 6 613 9 620 0.160 5.360.6
11-12 67 677 71618 9.761.3 0.861.2 7.5 6 3.3 49610 0.160 4.660.6
11-13 2262 9864 1360.9 0.260.1 7.660.6 51616 0.160 6.260.5
HKL
c 23627 3 610 12.560.9 0.2606 . 8 614 2 62 0.160 6.260.5
PBS
d 235649* 130615* 13.761.4 6.861.6* 18.1614 8 65 0.360.1 6.760.4
Ref. range 9–30 15–45 8–12 0.5–2.2 4.2–8.5 10–35 0–1 4.5–6.5
aMeans with standard deviations from Experiment 2 are displayed (n=4). Bold numbers: Significantly different from group immunized with heat-killed leptospires (one-
way ANOVA with Dunn’s post test, P,0.05). *Significantly different from group immunized with heat-killed leptospires (one-way ANOVA with Dunn’s post test,
P,0.01).
bAbbreviations: BUN, blood urea nitrogen; AlkPhos, alkaline phosphatase; Phos, phosphorus; SGPT, serum glutamic pyruvic transaminase.
cHeat-killed leptospires.
dPhosphate buffered saline.
doi:10.1371/journal.pntd.0001422.t003
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Tamm-Horsfall glycoprotein (THP), also known as uromodulin or
TAMM protein, a glycoprotein that is produced by renal tubular
epithelial cells [39]. THP is the most abundant protein in
mammalian urine and though its deposition, in and of itself, is
not pathologic, the high frequency of THP deposition in our study,
including one case with extensive tubular deposition that occurred
in an animal that succumbed to acute leptospirosis, suggests that
increased THP deposition is related to the pathogenesis of lep-
tospiral renal pathology. These physiologic hyaline deposits are
usually solid, but in our study all cases demonstrated both a solid
and ‘‘bubbly’’ deposition pattern. This ‘‘bubbly’’ pattern appeared
to be due to a pathological process rather than an artifact of
fixation and/or embedding, but further studies are needed to
confirm this conclusion.
Insufficient information is currently available to understand how
broadly LigA immunoprotection can be applied. Whereas ligB has
been found in all pathogenic Leptospira species, ligA has been found
in only L. interrogans and L. kirschneri [32]. L. interrogans serovar Lai is
the only L. interrogans isolate found not to contain ligA [40]. If ligA
deficiency is confirmed in other Lai isolates, this would be a
notable exception because the organism is both highly virulent
and epidemiologically important. Recently, it was reported that
homologous immunization with LigA7-13 that was expressed and
purified under denaturing conditions did not protect hamsters
against lethal infection by L. interrogans serovar Manilae strain
L495, an organism that expresses LigA [19]. This result stands
in stark contrast to previously successful immunization studies
involving L. interrogans serovars Manilae (strain UP-MMC-NIID),
Copenhageni and Pomona [27,28,41]. Although there were
differences in the strains and adjuvants used, the finding that
denatured LigA did not protect against lethal challenge could
indicate that the protective epitope is conformational rather than
linear. Accordingly, our finding that protective segments include
domains 11 and 12 plus a third domain (10 or 13) on either end,
suggests that three domains may be required for proper con-
formational folding. Additional research is needed to further de-
fine the structural requirements for LigA vaccine efficacy.
We strongly recommend daily weighing of animals in leptospiral
challenge experiments, including studies evaluating vaccine effi-
cacy. We found that 10% weight loss effectively identified animals
with leptospiral infection that had advanced to a premorbid
condition. A similar result was observed in a recent study of
leptospirosis in guinea pigs [42]. Weight loss is an objective end-
point criterion that avoids uncertainty about whether an animal is
able to eat and drink sufficient amounts of food and water. Thus,
weight should be monitored along with other clinical parameters
as different challenge doses or different strains may not present the
same pattern of disease.
In summary, we have mapped the immunoprotective segment
of LigA and determined the minimal number of domains ne-
cessary to protect hamsters from lethal infection. This work also
extends previous studies by quantifying the sublethal burden of
infection and by defining the renal histopathological consequences
of infection. It is worth noting that the immunoprotective domains
we identified are contained within a segment that is known to
mediate interactions with host extracellular matrix proteins [24].
This suggests that LigA-mediated immunoprotection may involve
interference with key leptospiral-host interactions rather than a
bactericidal mechanism. Further studies to define the kinetics of
leptospiral infection in immunized animals may provide insight
into both the mechanism of LigA-mediated immunoprotection
and the development of vaccines for sterilizing immunity against
leptospirosis.
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